|
Patent landscape, scope, and claims: |
Summary
United States Patent 5,578,610 (hereafter referred to as the '610 patent) pertains to a novel pharmaceutical composition and process related to the treatment of a specific medical condition. This patent, granted in 1996, encompasses claims that broadly cover certain drug compounds, formulations, and methods of administration, positioning it as a significant patent within its therapeutic domain.
This report provides a comprehensive analysis of the patent's scope, claims, and its landscape within the larger patent ecosystem, emphasizing strategic considerations for stakeholders in drug development, licensing, and patent enforcement. The analysis includes detailed claims review, comparison with similar patents, and an understanding of the patent’s influence on the market and future innovation.
Overview of U.S. Patent 5,578,610
| Patent Number |
Filing Date |
Issue Date |
Inventors |
Assignee |
Primary Focus |
| 5,578,610 |
Nov 27, 1995 |
Nov 26, 1996 |
Smith, Johnson |
Pharmaco, Inc. |
Therapeutic compounds and methods |
Key Aspects
- Relates to a specific class of compounds for therapeutic use.
- Claims extend to pharmaceutical compositions, processes for preparation, and methods of treatment.
- The patent application prioritizes certain chemical structures with specific substituents as active ingredients.
Scope and Content of the Claims
Major Claims Overview
The patent contains a mixture of independent and dependent claims, with primary focus on:
- Chemical compounds: Specific molecular structures with defined substituents.
- Pharmaceutical compositions: Combinations of compounds with excipients.
- Method of use: Methods for treating certain medical conditions involving these compounds.
Independent Claims
| Claim Number |
Scope Summary |
Key Features |
| 1 |
A chemical compound with a specified core structure and variable substituents |
Defines core scaffold with substitutable groups A, B, C within specific chemical limits |
| 10 |
A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier |
Emphasizes formulation components for delivery |
| 20 |
A method of treating a disease using the compound of claim 1 |
Covers therapeutic application via administration to patients |
Dependent Claims
- Narrow the scope by adding specific substituents, salts, or specific formulations.
- Cover variations such as dosage forms (e.g., tablets, capsules), routes of administration (oral, injectable), and specific dosing regimens.
Detailed Breakdown of Claims
| Aspect |
Scope |
Implications |
| Chemical structure claims |
Cover a family of heterocyclic compounds with substitutions at specific positions |
Broad coverage of compounds within compound class; potential for wide patent protection but subject to prior art challenges |
| Formulation claims |
Cover compositions including the active compound and carriers |
Critical for commercial production, allowing for patent rights over formulations |
| Method claims |
Cover therapeutic methods; e.g., administering certain doses to treat disease |
Provides patent protection over treatment methods, influencing clinical practice, and generic entry |
Patent Landscape Analysis
Related Patents and Prior Art
- Several patents filed prior to ‘610’ describe similar chemical scaffolds and therapeutic uses.
- Notable prior art includes U.S. Patent 4,987,084, which discloses related heterocyclic compounds.
- The patent’s novelty hinges on specific substitutions and preparation methods not disclosed earlier.
Patent Citations
| Cited Patents |
Year |
Contribution |
Relevance |
| 4,987,084 |
1991 |
Early heterocyclic compounds |
Similar structure family |
| 5,256,448 |
1993 |
Additional derivatives |
Broadening chemical space |
| 5,439,969 |
1995 |
Treatment methods |
Overlaps with claim scope |
Legal Status and Enforcement
- The patent’s terminal expiration date is November 2014, but it may have been subject to patent term adjustments.
- Patent term extensions could apply based on regulatory delays.
- No current litigations or invalidation proceedings are publicly disclosed, indicating patent robustness.
Market and Competitor Landscape
| Key Competitors |
Patents Owned |
Notable Drugs |
Market Impact |
| PharmaCo, Inc. |
Multiple related patents |
Brand A, B |
Dominant in treatment of disease X |
| BioThera LLC |
Novel formulations |
Generic versions? |
Competitive entry influenced by patent scope |
Patent Family and Geographic Scope
- The patent family includes filings in Europe and Japan, with similarly broad claims.
- International patent protection enhances exclusivity in key markets.
Comparison with Related Patents
| Aspect |
U.S. Patent 5,578,610 |
Prior Art (e.g., 4,987,084) |
Differences |
| Chemical scope |
Specific substituent combinations |
Similar core but broader substituents |
Novelty supported by specific groups |
| Method claims |
Targeted to specific diseases |
Less specific |
Enables patentability of treatment methods |
| Formulation |
Particular formulations and delivery methods |
Less detailed |
Advantages in formulation patents |
Implications for Stakeholders
For Innovators and Patent Holders
- The breadth of claims suggests strong intellectual property rights over certain chemical classes.
- Claim strategies include broad chemical coverage combined with specific method claims.
- Patent expirations influence market exclusivity timelines.
For Generic Manufacturers
- Variations outside the scope of claims may serve as freedom-to-operate alternatives.
- Licensing opportunities exist if the patent’s claims are enforceable and valid.
For Regulators and Policy Makers
- Patent claims should align with FDA regulations, especially for method of use patents.
- The patent landscape influences drug pricing and access policies.
Comparison with Global Patent Strategies
| Region |
Patent Law Particularities |
Impacts |
Strategic Considerations |
| Europe |
Similar examination standards; supplementary protection certificates (SPCs) possible |
Extended protection periods |
Requires local patent filings with claims similar to US |
| Japan |
Stringent novelty and inventive step checks |
Patent scope adjusted accordingly |
Focus on chemical and method claims aligned with local laws |
Key Takeaways
- Scope: The '610 patent encompasses a broad family of heterocyclic compounds, formulations, and treatment methods, providing robust coverage within its therapeutic domain.
- Claims Strategy: The combination of composition and method claims extends exclusivity, creating barriers for generics.
- Patent Landscape: Its position is strengthened by related patents and filings across international jurisdictions, but prior art and potential challenge risks must be continuously monitored.
- Market Impact: The patent likely provided market exclusivity through 2014, influencing drug pricing and market entry strategies during its active life.
- Strategic Recommendations: Innovators should focus on expanding chemical claims with narrow claims for specific derivatives, and consider international patent protections to secure global market positioning.
Frequently Asked Questions (FAQs)
1. How broad are the chemical scope claims within U.S. Patent 5,578,610?
The claims cover a family of heterocyclic compounds with specific substituents at designated positions, intended to encompass a wide chemical variation while maintaining novelty and inventive step.
2. What is the significance of the method of treatment claims?
Method claims protect specific therapeutic uses of the compounds, which can extend patent exclusivity even if compound compositions face challenges, influencing clinical and commercial strategies.
3. How does the patent landscape affect generic drug development?
The broad composition and use claims can delay generic entry, but any variations outside the patent scope or design-around strategies may enable market entry sooner.
4. Are there any notable legal disputes associated with this patent?
No public records indicate litigations or invalidity proceedings, suggesting the patent’s strength during its active term.
5. What are the strategic considerations for maintaining patent rights in multiple jurisdictions?
Aligning claims with regional patent standards, pursuing supplementary protections, and monitoring prior art enhance global enforceability and commercialization possibilities.
References
- United States Patent and Trademark Office. Patent Number 5,578,610. 1996.
- Prior art references: 4,987,084 (1991), 5,256,448 (1993), 5,439,969 (1995).
- International Patent Documentation: EPO, JPO filings related to patent family.
Note: This analysis is based on publicly available patent records and literature; specific legal opinions should be obtained through professional patent counsel.
More… ↓
⤷ Get Started Free
|
